Management of prescription and nonprescription drug use during pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 8, 2010, Pages 813-819

  Morgan, Maria A ^a   Cragan, Janet D ^b   Goldenberg, Robert L ^c   Rasmussen, Sonja A ^b   Schulkin, Jay ^a  

^a INTER AMERICAN DEVELOPMENT BANK   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Over the counter; prescription; questionnaire; safety; teratogenic

Indexed keywords

ALCOHOL; ILLICIT DRUG; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG; DRUG;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; FEMALE; GYNECOLOGY; HUMAN; MALE; OBSTETRICS; PATIENT REFERRAL; PHYSICIAN; PHYSICIAN ATTITUDE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; CLINICAL PRACTICE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; MALE; MIDDLE AGED; OBSTETRICS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY;

EID: 77954730566     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903387045     Document Type: Article

References (30)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-344.
2. Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) 2005;14:104-109.
3. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol 2008; 451:106-118.
4. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-777.
5. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Philadelphia: Lippincott Williams & Wilkins; 2008. 2144 p.
6. Wilson RD, Johnson JA, Summers A, Wyatt P, Allen V, Gagnon A, Langlois S, Blight C, Money DM, Boucher M, et al. Principles of human teratology: drug, chemical, and infectious exposure. J Obstet Gynaecol Can 2007;29:911-926.
7. Henshaw SK. Unintended pregnancy in the United States. Fam Plan Perspect 1998;30:24-29.
8. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-96.
9. Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol 2005;22:321-324.
10. Li DK, Liu L, Odouli R. Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368-372.
11. Glover DD, Rybeck BF, Tracy TS. Medication use in a rural gynecologic population: prescription, over-the-counter, and herbal medicines. Am J Obstet Gynecol 2004;190: 351-357.
12. Friedman JM. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 2000;62: 134-137.
13. Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol 2005; 105:1119-1122.
14. Ernst E. Herbal medicines: where is the evidence? BMJ 2000;321:395-396.
15. Cragan JD, Friedman JM, Holmes LB, Uhl K, Green NS, Riley L. Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Matern Child Health J 2006;10: S129-S135.
16. Heyes T, Long S, Mathers N. Preconception care: practice and beliefs of primary care workers. Fam Pract 2004;21:22-27.
17. Morgan MA, Hawks D, Zinberg S, Schulkin J. What obstetrician- gynecologists think of preconception care. Matern Child Health J 2006;10:S59-S65.
18. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: national findings. http://www.oas.samhsa.gov/nsduh/ 2k6nsduh/2k6Results.pdf. Last accessed 2 January 2009.
19. ACOG. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. ACOG Committee Opinion No. 422. Obstet Gynecol 2008;112:1449-1460.
20. Morgan MA, Schulkin J. Obstetrician-gynecologists and selfidentified depression: personal and clinical. Depress Anxiety 2006;23:83-89.
21. Schmidt LA, Greenberg BD, Holzman GB, Schulkin J. Treatment of depression by obstetrician-gynecologists: a survey study. Obstet Gynecol 1997;90:296-300.
22. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
23. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002; 100:465-473.
24. Rahimi R, Nikfar S, Abdollahi M. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a metaanalysis of clinical trials. Reprod Toxicol 2006;22:571-575.
25. Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007;16:1086-1094.
26. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356: 2684-2692.
27. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotoninreuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-2683.
28. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod 2009;24:146-153.
29. Hill LD, Erickson K, Holzman GB, Power ML, Schulkin J. Practice trends in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 1995-2000. Obstet Gynecol Surv 2001;56:505-516.
30. Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M, Haas JS. Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) 2005;14:401-409.